Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDHP5303/11
CompoundBurprenorphine
Trials sponsorGrünenthal GmbH
Trial phase1
Brief titleSingle dose trial comparing the plasma levels of two different analgesic transdermal patch formulations
IndicationCentrally acting analgesic
UTN
CTG IDNCT00388219
CTIS ID (former EudraCT)2006-003178-90
Trial statusTerminated
FPINovember 6, 2006
LPODecember 14, 2006
CountriesGermany
GenderMale
Age18-55 years
ResultsNo
Pubmed
Documents
HP5303-11 | Grünenthal